Vaccine World Summit 2011 India’s biggest vaccine conference

Location: New Delhi, India
Time: 1 st -3 rd of March

Event Partner: DCVMN
Host: IMAPAC

For Full details and to download the brochure for free visit www.imapac.com / vaccineindia2011

India’s biggest vaccine conference Vaccine World Summit 2011 will be from the 1 st to the 3 rd of March 2011, in New Delhi. The event will be hosted by IMAPAC, in partnership with DCVMN (Developing Countries Vaccine Manufacturers Network).

Participants will be discussing strategies to tackle global public health challenges including appropriate pandemic surveillance programs, low cost and fast vaccine manufacturing technologies, innovative adjuvants and delivery systems, vaccine research funding opportunities and the latest clinical results of new and next generation vaccines fighting life-threatening infectious diseases such as cholera, malaria, dengue, AIDS and rotavirus infection, just to name a few.

Come to learn and network with the knowledge leaders in the fields of vaccine research, vaccine manufacturing, delivery systems and adjuvants .

Vaccine World Summit is where:

· The best of the BEST vaccine manufacturing experts from India and internationally gather
· 150+ vaccine decision makers come together to discuss latest research and manufacturing trends, strategies, technology advancement and best practices
· Latest developments in products, process technologies, IP, quality, and regulatory developments are shared and discussed
· Manufacturers, regulators, CMOs, regional development agencies, technology and service providers and other stakeholders convene

Key speakers include:

Jaques Cholat , Vice President, Commercial Operations - International , Sanofi Pasteur, France
Sri Prasanna Kumar Pradhan , Additional Secretary and Mission Director, National Rural Health Mission, India
Reinhard Gluck, CSO , Zydus Cadila , India
K V Balasubramaniam , Managing Director, Indian Immunologicals Ltd, India
Suresh Jadhav , Executive director, Serum Institute of India, India

Nihal Abeysinghe , Regional Advisor, Vaccine Preventable Diseases , World Health Organization, South-East Asia Region, India
Hemant Bramhne , Director, CRI Kasauli , India
Arun Bharadwaj , Director, National Control laboratory Kasauli , India
Michael Callahan MD , Director, Emergency Vaccine Manufacturing , DARPA, USA
Lakshmi Khandke , Director, Formulation Development, Pfizer Vaccine Research, USA

Bakulesh Khamar , Executive Director, Research, Cadila Pharmaceuticals, India
Nikolai Petrovsky , Chairman, Vaxine , Austrailia
Rajeev M Dhere , Senior Director Manufacturing, Serum Institute of India, India
Shirshendu Mukherjee , Strategic advisor, Wellcome Trust, India
Altaf Lal , CEO, MSD Wellcome Trust Hilleman Laboratories, India

Krishna M. Ella, Chairman & Managing Director , Bharat Biotech International Limited, India
Sudeep Srivastava , General Manager - Biotechnology , CPL Biologicals , India
G Balakrish Nair, Director, National Institute of Cholera and Enteric Diseases, India
Leonard P. Ruiz , President, International Medica Foundation, USA
Virander S. Chauhan , Director , International Centre for Genetic Engineering and Biotechnology, India

Gurdyal Kalsi , VP Global Clinical Development, Emergent Biosolutions , UK
B.G. Rhee , President, Green Cross Corporation, Korea
Mahima Datla , SVP Biotechnology and projects, Biological E, India
Anders Fomsgaard , Department of Virology, Statens Serum Institut , Denmark
K.R.S. Krishnan, Senior Executive Director, Research and Development and Strategic Planning, HLL Lifecare Limited, India

L. S. Chauhan , Director , National Centre for Disease Control, India
Mae Shieh , Business Development & Partnerships, Novartis Vaccines Institute for Global Health, Italy
Rajiv Khanna Director, Australian Centre for Vaccine Development, Australia
P. R. Ramdas , Head – Plant Engineering & HSE , Intervet , India
Nagendra Hegde , Group leader of Virology , Ella Foundation, India

K Sumathy , Associate director of R&D, Bharat Biotech International Limited , India
Michael Royals, Chief Scientific Officer, Pharmajet , USA
C S Jambaladinni , Associate Director (Production) Ranbaxy Laboratories Limited , India
Josemund Menezes Regional Director, Clinical Development (Asia-Pac), Sanofi -Pasteur, India
Vidadi Yusibov , Executive Director Fraunhofer Center for Molecular Biotechnology , USA

Event language : English

Sponsors:

Pall:

Pall Life Sciences provides cutting-edge products and services to meet the demanding needs of customers discovering, developing and producing biotech drugs, vaccines and classic pharmaceuticals. Pall is a leading provider of separation systems and single-use filtration and purification technologies to pharmaceutical and biotechnology companies to support faster development of new drugs and vaccines that are safer and require less energy and water to produce. Pall’s Scientific and Laboratory Services (SLS), Technical Services and Validation Laboratories have been a cornerstone of customer support for over 30 years. The company maintains certified ISO9001 manufacturing facilities worldwide.

http://www.pall.com/

Pharmajet :

Headquartered in Golden, CO, USA, PharmaJet ® was founded in 2005 with the mission to enhance developing world healthcare by providing a safe, affordable and less painful means of vaccine and drug delivery to more people in more places.

With clearances in the US, Europe, Brazil and India, the spring-operated PharmaJet ® needle-free injection system delivers vaccines and medications in a 0.5mL volume, either intramuscularly or subcutaneously by means of a narrow, high velocity fluid jet, which penetrates the skin.

http://www.pharmajet.com/

Aptar :

The AptarGroup family of companies is the leader in the global dispensing systems industry. We have over half a century of experience operating in the ever-changing consumer packaging world. We are a unique customer and shareholder focused company with proprietary knowledge, technical expertise, broad product range, and approximately 9,000 dedicated employees in 19 different countries. Our stock trades on the New York Stock Exchange with the symbol ATR.

http://www.aptargroup.com/index.asp

Exhibitors:

Sartorius Stedim :

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on –using lese technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions”.

Headquartered in Aubagne , France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs approximately 2,400 people, and in 2009 earned sales revenue of 401.2 million euros .

http://www.sartorius-stedim.com/index.php?id=4387

For more information, please contact:
Romilly Sinclair
Tel: +65 64932095
Or visit the website: www.imapac.com / vaccineindia2011